Practice Intervention Targeting IV Opioids May Cut Exposure

Share this content:
Practice Intervention Targeting IV Opioids May Cut Exposure
Practice Intervention Targeting IV Opioids May Cut Exposure

MONDAY, May 13, 2018 (HealthDay News) -- An intervention targeting the use of intravenous opioids may reduce opioid exposure, according to a study published online May 14 in JAMA Internal Medicine.

Adam L. Ackerman, M.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues conducted a pilot study involving attending physicians, nurse practitioners, and physician assistants who prescribed drugs. Opioid use was compared between a six-month control period and three months following education for prescribers on opioid administration routes, focusing on awareness of the subcutaneous routes.

The researchers observed an 84 percent reduction in intravenous opioid doses and a 55 percent reduction in doses of all parenteral opioids. In addition, there was a 49 percent decrease in the mean daily parenteral opioid exposure. There was a 57 percent decrease in the daily rate of patients administered any parenteral opioid. Reductions were seen in doses of opioids given by oral or parenteral route (23 percent) and mean daily overall opioid exposure (31 percent). For hospital days one through three, there were no significant differences in mean reported pain score for patients receiving opioid therapy post-intervention versus pre-intervention; there was significant improvement in the intervention group on days four and five.

"An intervention targeting the use of intravenous opioids may be associated with reduced opioid exposure while providing effective pain control to hospitalized adults," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »